Oscar Tahuahua, Medical Oncology Fellow at the National Cancer Institute of Mexico, shared a post on X about a paper by published in Cancer Treatment Reviews:
“Triple M (myasthenia+myositis+myocarditis) from ICIs – 38% mortality (50% resp. failure, 41% tox)
ICI neurotoxicity: 0.24% in trials, 2–4% of irAEs; 40–60% lasting deficits, 6–17% mortality
ACT FAST: steroids + intensive cardio-resp. monitoring.”
Title: Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis
Authors: Dorte Lisbet Nielsen, Carsten Bogh Juhl, Inna Markovna Chen, Yinghong Wang, Ole Haagen Nielsen, Bianca Denise Santomasso.
You can read the Full Article on Cancer Treatment Reviews.
More posts featuring Oscar Tahuahua.
